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This bulletin presents key findings on polydrug use (the use of more than one substance within a specific time 
period) in Ireland and Northern Ireland. It presents data collected in the All Ireland Drug Prevalence Survey 
2006/2007 relating to polydrug use on a last month (current use) basis. The focus is on the combinations of both 
legal and illegal drugs based on information obtained from the second drug prevalence survey of households. The 
bulletin also examines gender and age differences and the relationship between the use of a particular substance 
and the use of another substance. The survey was carried out by Ipsos MORI in Ireland and by the Central Survey 
Unit of the Northern Ireland Statistics and Research Agency in Northern Ireland according to standards set by the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Drug Use in Ireland and 
Northern Ireland
2006/2007 Drug Prevalence Survey: Polydrug Use Results
Bulletin 5
1National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2009
Ireland –  
Key Findings
n	One-fifth (20%) of all adults aged 15-64 
in Ireland had not used any drugs (legal 
or illegal) in the last month.
n	The most commonly reported form of 
polydrug use is a combination of alcohol 
and tobacco.
n	Five percent of all adults had used 
tobacco only in the previous month.
n	Among all adults, polydrug use involving 
any illegal drugs is small at 3%.
n	A higher percentage of females (23%) than 
males (17%) had not used any drugs 
(legal or illegal) during the last month.
n	Combined use of alcohol and tobacco 
was more frequently reported by males 
(29%) than females (24%).
n	The combination of alcohol, tobacco 
and any illegal drugs was more common 
among males (3%) than females 
(0.9%).
n	A larger proportion of young adults aged 
15-34 (31%) reported using a 
combination of alcohol and tobacco than 
older adults aged 35-64 (23%).
n	Just over four-fifths (81%) of those who 
had smoked tobacco, had also used 
alcohol in the last month.
n	The majority of current cannabis users 
also reported using alcohol (91%) and 
tobacco (88%).
Northern Ireland – 
Key Findings
n	Just over one-fifth (21%) of all adults 
aged 15-64 in Northern Ireland had not 
used any drugs (legal or illegal) in the 
last month.
n	The most commonly reported form 
of polydrug use among all adults is a 
combination of alcohol and tobacco;  
this is also true for gender and age.
n	Four percent of all adults had used 
tobacco only in the previous month.
n	Among all adults, polydrug use involving 
any illegal drugs is small at 2%.
n	A higher percentage of females (24%) than 
males (18%) had not used any drugs 
(legal or illegal) during the last month.
n	Combined use of alcohol and tobacco 
was more frequently reported by males 
(21%) than females (16%).
n	A larger proportion of young adults 
aged 15-34 (23%) reported using a 
combination of alcohol and tobacco  
than older adults aged 35-64 (15%).
n	Over three-quarters (78%) of all adults 
who had smoked tobacco, had also used 
alcohol in the last month.
n	The majority of current cannabis users 




Comparison –  
Key Findings
n	Approximately one-fifth of all adults in 
both Northern Ireland (21%) and Ireland 
(20%) had not used any drugs (legal or 
illegal) in the last month.
n	The most common form of polydrug use 
among all adults is a combination of 
alcohol and tobacco for both jurisdictions 
and is more prevalent in Ireland (27%) 
than in Northern Ireland (18%).
n	Similar proportions of respondents 
smoked tobacco only in both Ireland 
(5%) and Northern Ireland (4%), while 
a larger proportion of respondents 
consumed alcohol only in Ireland (50%) 
than in Northern Ireland (43%).
n	Combinations that involved the use 
of sedatives or tranquillisers and anti-
depressants were generally higher among 
older adults than young adults in both 
jurisdictions.
n	In both Ireland and Northern Ireland, 
combinations that involved the use of 
any illegal drugs were reported by a 
small minority of respondents.
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Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Public Health 
Information and Research Branch (PHIRB), formerly known as 
the Drug and Alcohol Information and Research Unit (DAIRU), 
within the Department of Health, Social Services and Public 
Safety (DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence rates for 
key illegal drugs, such as cannabis, ecstasy, cocaine and heroin, 
on a lifetime (ever used), last year (recent use), and last month 
(current use) basis. Similar prevalence questions were also asked 
of alcohol, tobacco, and other drugs such as sedatives, 
tranquillisers and anti-depressants. Attitudinal and demographic 
information was also sought from respondents.
Methodology
The questionnaire and methodology for this survey were based 
on best practice guidelines drawn up by the EMCDDA. The 
questionnaires were administered through face-to-face interviews 
with respondents aged between 15 and 64 normally resident in 
households in Ireland and Northern Ireland. Thus persons 
outside these age ranges, or who do not normally reside in 
private households, have not been included in the survey. This 
approach is commonly used throughout the EU and because of 
the exclusion of those living in institutions (for example, prisons, 
hostels) this type of prevalence survey is usually known as a 
general population survey.
Fieldwork for the survey was carried out between October 2006 
and May 2007 and the final achieved sample was 6,969 (4,967 
in Ireland and 2,002 in Northern Ireland). The response rate for 
the survey was 65% in Ireland and 62% in Northern Ireland. 
Area based sampling was applied in Ireland. The first stage 
involved stratifying by Health Board1/Regional Drugs Task Force 
(RDTF) area in Ireland. Within the Health Board/RDTF strata 
Electoral Divisions (EDs) were selected as areas. In Northern 
Ireland, the first stage involved stratifying by Health and Social 
Services Board (HSSB) areas and within the strata simple 
random sampling was used. The achieved sample was weighted 
by gender, age, RDTF area in Ireland and HSSB area in Northern 
Ireland, to maximise representativeness of the general 
population. The effects of stratification, clustering and weighting 
have been incorporated in the interval estimates (i.e. design 
1  Since January 2005 the Health Boards in Ireland have undergone 
restructuring and are merged under one authority – the Health Service 
Executive. However for the purpose of comparison with 2002/3 data, we 
have continued to weight the data by the former Health Board areas as 
these correspond with the Regional Drugs Task Force (RDTF) structures. 
The above reference relates to the Health Board structures details in 
Bulletin 2: Drug Use in Ireland and Northern Ireland 2002/2003 Drug 
Prevalence Survey – Health Board (Ireland) & Health and Social Services 
Board (Northern Ireland) Results (Revised) June, 2005. 
effect adjusted). Details of the methodology have been 
published on the websites of the NACD (http://www.nacd.ie/) 
and the DHSSPS (http://www.dhsspsni.gov.uk/) in 
comprehensive technical reports containing copies of the 
questionnaires used in each jurisdiction.
The Research Advisory Group (RAG) decided to change from 
using a pen and paper interviewing technique to computer-
assisted personal interviewing (CAPI), where the interviewer 
records responses electronically. This technique has several 
advantages: interviews can be administered more quickly; human 
error is minimised, yielding higher-quality data; and data input is 
managed more efficiently, thus cutting costs.2
What is Prevalence?
The term prevalence refers to the proportion of a population 
who has used a drug over a particular time period. In 
general population surveys, prevalence is measured by 
asking respondents in a representative sample drawn from 
the population to recall their use of drugs. The three most 
widely used recall periods are: lifetime (ever used a drug), 
last year (used a drug in the last twelve months), and last 
month (used a drug in the last 30 days). Provided a sample 
is representative of the total population, prevalence 
information obtained from a sample can be used to infer 
prevalence in the population.
Lifetime prevalence refers to the proportion of the sample 
that reported ever having used the named drug at the time 
they were surveyed. A person who records lifetime 
prevalence may – or may not – be currently using the drug. 
Lifetime prevalence should not be interpreted as meaning 
that people have necessarily used a drug over a long period 
of time or that they will use the drug in the future.
Last year prevalence refers to the proportion of the sample 
that reported using a named drug in the year prior to the 
survey. For this reason, last year prevalence is often referred 
to as recent use.
Last month prevalence refers to the proportion of the 
sample that reported using a named drug in the 30 day 
period prior to the survey. Last month prevalence is often 
referred to as current use. A proportion of those reporting 
current use may be occasional (or first-time) users who 
happen to have used in the period leading up to the survey 
– it should therefore be appreciated that current use is not 
synonymous with regular use.
2  EMCDDA Handbook on Population Surveys.
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As with other European surveys, people over the age of 64 are 
excluded from this survey, as they grew up in an era when both 
the use and availability of illegal drugs were very limited. 
Therefore surveys with older people have, to date, shown very 
low rates of use even on a lifetime basis. This situation will 
change over time as the younger population grows older. Hence 
lifetime prevalence rates are likely to increase for a considerable 
period of time. When examining the data and comparing results 
over time, last year use is the best reflection of changes as it 
refers to recent use. Last month use is equally valuable as it 
refers to current use.
Previous Publications
First results from the second Drug Prevalence Survey 
2006/2007 were published in Bulletin 1 (January 2008). It gave 
lifetime, last year and last month prevalence rates for key drugs 
for the Island of Ireland, Ireland and Northern Ireland.
Bulletin 2, published in June 2008, contained comparable 
information for Ireland and its constituent Regional Drugs Task 
Force areas (former Health Board areas) and Northern Ireland 
and its constituent Health and Social Services Board areas.
Bulletin 3 (2006/7 Drug Prevalence Survey: Cannabis Results) 
was published in December 2008, it examines age of first use; 
regular use; type of cannabis used; method by which cannabis is 
used; how and where cannabis is obtained; reasons for stopping 
use; attitudes to cannabis use and perceptions of risk, together 
with the typical profile of cannabis users.
Bulletin 4 (2006/7 Drug Prevalence Survey: Cocaine Results) 
was published in October 2008 and contains prevalence rates 
for the use of cocaine (cocaine powder or crack cocaine) and 
other information relating to cocaine use in Ireland and Northern 
Ireland for 2006/7 and also provides comparison information 
between 2002/3 and 2006/7. Results are given for all 
respondents, and are also presented by gender and by age 
(young adults aged 15-34 and older adults aged 35-64).
Bulletin 6 (2006/7 Drug Prevalence Survey: Sedatives or  
Tranquillisers, and Anti-depressants Results) was published in 
March 2009 and contains prevalence rates for the use of 
sedatives or tranquillisers, and anti-depressants and other 
information in relation to sedative or tranquilliser and anti-
depressant use in Ireland and Northern Ireland for 2006/7. 
Results are given for all respondents, and are also presented by 
gender and by age (young adults aged 15-34 and older adults 
aged 35-64).
Understanding the Results  
in this Bulletin
This bulletin (Bulletin 5) is concerned with polydrug use, that is, 
the use of more than one drug within the last month, in Ireland 
and Northern Ireland. Results are given for all respondents aged 
15-64, by gender and by age (young adults aged 15-34 and 
older adults aged 35-64) based on data provided for last month 
use.
Readers should note that the total sample size for each group is 
given at the head of each column. All prevalence rates presented 
in the accompanying tables are rounded to one decimal place 
and are rounded to whole numbers in the text (except for 
percentages less than 1%).
As in all sample surveys, the greater the sample size the more 
statistically reliable are the results. Some of the differences in 
prevalence rates in the tables will be attributable to natural 
sample variations. Detailed confidence intervals for all individual 
drug prevalence rates can be found on the websites of the 
NACD and DHSSPS. Confidence intervals are not available for 
the polydrug combinations listed in this bulletin.
Invalid responses have been excluded from all analyses. 
Percentages may not always sum to 100 due to either the effect 
of rounding or where respondents could give more than one 
answer. Where the figure 0.0% appears it does not mean that 
no-one has used the drug, rather it means that in this category 
no respondent reported use.
In 2006/7, the Z-Test was used to compare differences in 
polydrug use for selected variables such as gender, age etc and 
between the findings in Ireland and Northern Ireland. The Chi-
Square examined the association between the use of one 
substance and the use of other substances. For the purposes of 
this study, a p-value of less than 0.05 indicated that a true 
association or relationship existed and the differences were not 
due to chance. It should be noted, that due to small cell counts 
for some of the polydrug combinations the chi-square test was 
not appropriate to determine associations.
Interpreting the Data
In each of the tables:
n	All figures are based on weighted data
n	All figures are rounded to the nearest decimal place
n	All figures are based on valid responses
n	Data is based on last month use
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For the purpose of this study:
n	‘legal drugs’ refers to alcohol, tobacco, sedatives or 
tranquillisers, and anti-depressants
n	‘any illegal drugs’ refers to amphetamines, cannabis, cocaine 
powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents
n	‘no legal or illegal drugs’ refers to none of the above 
specified (legal or illegal) drugs in the last month – this 
category has replaced the ‘Nothing’ category in the previous 
Bulletin 5 (2002/2003).
Definition of Polydrug Use
There are a number of forms of polydrug use. The most general 
definition (and the form reported here) is concurrent drug use, 
which involves a person using at least two substances during the 
same time period (for example, having used both cocaine and 
ecstasy in the last month).
Polydrug use is associated with a number of negative 
consequences including mental and physical ill-health, violence, 
aggression and a range of social problems. Polydrug use is more 
likely to result in accidents and death (including death from 
overdose) than when a single substance is consumed.
There is evidence that polydrug use is common among people 
seeking drug treatment. The majority of cases treated in 2007 in 
Ireland reported problem drug use of more than one substance 
(67%), which was slightly lower than in 2006 (71%). Polydrug 
use increases the complexity of these cases, and is associated 
with poorer treatment outcomes (HRB 2009)3. Earlier research 
shows that the pattern of ‘additional’ drugs was linked to the 
main problem drug, the most common additional problem drugs 
were cannabis followed by benzodiazepines, other opiates and 
then cocaine (HRB 2005)4.
In considering the results presented here, note that the figures 
for prevalence are for that specific combination of drugs ONLY. 
Thus, the figures for alcohol only, refers to that group of people 
who consumed alcohol only, i.e. that group did not use any 
other substance, during that specified interval. A higher 
percentage than this will actually have consumed alcohol,  
but will also have used another substance (for example, smoked 
tobacco). The important point is that the tables presented in this 
report are not aimed at presenting information on the prevalence 
of individual substances but rather at the combination of drugs.
3 Alcohol and Drug Research Unit of the Health Research Board (2009) 
Treated problem drug use in Ireland: Figures for 2007 from the National 
Drug Treatment Reporting System. Available at www.hrb.ie/publications.
4 Drug Misuse Research Division of the Health Research Board (2005), 
Trends in treated problematic drug use in Ireland, 1998 to 2002, 
Occasional Paper No. 17/2005.
Future Publication
A further publication from the Drug Prevalence Survey will 
present analysis of data on alcohol use for Ireland only.
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Results – Ireland
Polydrug Use – Last Month Prevalence
All adults (Table 1)
Results from Table 1 show that one-fifth (20%) of the adult 
population aged 15-64 in Ireland had not used any drugs (legal  
or illegal) in the last month. In other words a large proportion  
of adults are not current users of any substance. 
While the largest proportion of respondents (50%) had consumed 
alcohol only, the most frequent combination of polydrug use 
involved the two most familiar legal substances, i.e. alcohol and 
tobacco (26%). Five percent of respondents had used tobacco only.
Looking at the overall figures, the percentages involving other 
forms of polydrug use, (apart from the combination of alcohol 
and tobacco) was low. The second most frequently reported 
combination of polydrug use was alcohol, sedatives or 
tranquillisers and anti-depressants (3%) followed by alcohol and 
any illegal drugs (3%) and tobacco and any illegal drugs (2%). 
Again, it should be noted that these drug use combinations do 
not indicate the level of consumption of any individual drug on 
its own. The proportions of all adults reporting various other 
polydrug combinations range from 0.1% to 2.3%.
Gender (Tables 2 & 3)
A higher percentage of females (23%) than males (17%) had not 
used any drugs (legal or illegal) during the last month. Also, 
higher percentages of females than males reported using tobacco 
only (7% and 3%, respectively), alcohol, sedatives or tranquillisers 
and anti-depressants (4% and 2%, respectively), tobacco, sedatives 
or tranquillisers and anti-depressants (3% and 2% respectively), 
alcohol and anti-depressants (2% and 1%, respectively) and 
tobacco and anti-depressants (2% and 1%, respectively).
Higher percentages of males than females reported using alcohol 
and tobacco (29% and 24%, respectively), alcohol and any 
illegal drugs (4% and 1%, respectively), tobacco and any illegal 
drugs (4% and 1%, respectively) and alcohol, tobacco and any 
illegal drugs (3% and 0.9%, respectively).
Age (Tables 4 & 5)
A comparison of young and older adults in Ireland shows a 
number of similarities and differences. A similar proportion of 
young adults (20%) and older adults (19%) reported they had 
not used any drugs (legal or illegal) in the last month. A larger 
proportion of young adults (31%) than older adults (23%) 
reported using alcohol and tobacco, and also the combination  
of alcohol and any illegal drugs (5% and 1% respectively), 
tobacco and any illegal drugs (4% and 1% respectively) and  
the combination of alcohol, tobacco and any illegal drugs (4% 
and 0.8% respectively).
However, larger proportions of older adults than young adults 
reported using alcohol only (53% and 47% respectively) and 
the following combinations: alcohol, sedatives or tranquillisers 
and anti-depressants (4% and 2%, respectively); tobacco, 
sedatives or tranquillisers and anti-depressants (3% and 1%, 
respectively); alcohol, sedatives or tranquillisers (3% and 0.9% 
respectively); alcohol and anti-depressants (2% and 1%, 
respectively); tobacco and sedatives or tranquillisers (2% and 
0.6% respectively); tobacco and anti-depressants (2% and 1% 
respectively); sedatives or tranquillisers and anti-depressants  
(1% and 0.6%, respectively); and alcohol, tobacco and anti-
depressants (1% and 0.4%).
Relationship between use of particular 
substances and use of other substances  
– All adults (Table 6)
Patterns of polydrug use change when the data for specific drugs 
used was analysed. This table presents the pattern of association 
between the use of one substance and the use of another. For 
example, of those respondents who used alcohol (3653), 36% 
also used tobacco and 3% also used cannabis in the last month.
In general the commonly used legal substances (alcohol and 
tobacco) are associated with less use of other substances than 
vice-versa. Thus, it can be seen that of those who had smoked 
tobacco, over four-fifths (81%) had drunk alcohol. However, for 
both of these substances, the proportion of respondents using 
them in combination with other legal or illegal drugs was quite low.
In contrast, users of cannabis, amphetamine-type stimulants, and 
cocaine were more likely to have used legal substances as well as 
other illegal substances. For example, of those who had used 
cannabis within the last month, the vast majority (91%) had used 
alcohol and 88% had smoked tobacco. Of those who had used 
amphetamine-type stimulants, all (100%) had used alcohol, 84% 
had used tobacco, 79% cannabis, 33% cocaine, 5% had used 
sedatives or tranquillisers and 5% had used anti-depressants.
Use of one substance by users of another 
substance – Gender (Tables 7 & 8)
When comparing alcohol consumption amongst males and females, 
there is no consistent pattern. Of those who had used alcohol, 
males (5%) were more likely than females (1%) to also use 
cannabis. Conversely, larger proportions of female than male users 
of alcohol reported also using sedatives or tranquillisers (3% and 
2%, respectively) and anti-depressants (4% and 2%, respectively).
Among users of tobacco, larger proportions of males than 
females reported also using alcohol (88% and 74%, 
respectively) and cannabis (11% and 3%, respectively), while 
larger proportions of females than males reported also using 
sedatives or tranquillisers (5% and 3%, respectively) and anti-
depressants (6% and 3%, respectively).
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Among users of anti-depressants, larger proportions of males (9%) 
used cannabis than females (3%) and similarly among users of 
sedatives or tranquillisers, larger proportions of males (7%) than 
females (3%) also used cannabis. It should be noted, that due 
to small cell counts for some of the polydrug combinations the 
chi-square test was not appropriate to determine associations.
Use of one substance by users of another 
substance – Age (Tables 9 & 10)
Differences between young adults aged 15-34 and older adults 
aged 35-64 in the use of many of the substances were 
observed, mainly for alcohol and tobacco. Among users of 
alcohol, larger proportions of young adults than older adults 
reported using tobacco (41% and 31%, respectively), cannabis 
(5% and 1%, respectively) and amphetamine-type stimulants 
(1% and 0.1%, respectively). However, larger proportions of 
older adults than young adults who used alcohol also reported 
using sedatives or tranquillisers (4% and 1%, respectively) and 
anti-depressants (3% and 2%, respectively).
Similar results were observed among users of tobacco, where 
larger proportions of young adults than older adults reported 
also using alcohol (85% and 78%, respectively), cannabis (10% 
and 3%, respectively) and cocaine (2% and 0.1%, respectively). 
In contrast, larger proportions of older adults than young adults 
who were users of tobacco reported also using sedatives or 
tranquillisers (7% and 2%, respectively) and anti-depressants 
(7% and 3%, respectively). It should be noted, that due to 
small cell counts for some of the polydrug combinations the  
chi-square test was not appropriate to determine associations.
Results – Northern Ireland
Polydrug Use – Last Month Prevalence
All adults (Table 11)
Just over one-fifth (21%) of all adults aged 15-64 in Northern 
Ireland had not used any drugs (legal or illegal) in the last 
month. The largest proportion of respondents (43%) had 
consumed alcohol only, and the most frequent combination of 
polydrug use was alcohol and tobacco (18%). Four percent of 
respondents had used tobacco only.
The percentage of respondents reporting polydrug use 
(excluding the combination of alcohol and tobacco) was low. 
The second most frequently reported combination of polydrug 
use was alcohol, tobacco and any illegal drugs (2%), followed 
by alcohol and any illegal drugs (1%) and alcohol and anti-
depressants (1%). The proportions of all adults reporting various 
other polydrug use combinations ranged from 0.1% to 1%.
Gender (Tables 12 & 13)
A higher percentage of females (24%) than males (18%) had 
not used any drugs (legal or illegal) during the previous month. 
Also, a higher percentage of females than males reported using 
alcohol and anti-depressants (2% and 0.5%, respectively) and 
tobacco, sedatives or tranquillisers and anti-depressants (2% 
and 0.4%, respectively).
Larger proportions of males than females reported using alcohol 
only (46% and 40%, respectively), alcohol and tobacco (21% 
and 16%, respectively) and alcohol and any illegal drugs (2% 
and 0.6%, respectively).
Age (Tables 14 & 15)
A comparison of young and older adults in Northern Ireland 
shows a number of similarities and differences. A similar 
proportion of young adults (22%) and older adults (20%) 
reported they had not used any drugs (legal or illegal) in the 
last month. A larger proportion of young adults (23%) than 
older adults (15%) reported using alcohol and tobacco, and 
also the combination of alcohol and any illegal drugs (2% and 
0.2%, respectively). However, larger proportions of older adults 
than young adults reported using the following combinations: 
alcohol and anti-depressants (2% and 0.3%, respectively); 
alcohol and sedatives or tranquillisers (2% and 0.3%, 
respectively); alcohol, tobacco, sedatives or tranquillisers and 
anti-depressants (1% and 0.4%, respectively); sedatives or 
tranquillisers and anti-depressants (1% and 0.3%, respectively); 
and alcohol, tobacco and sedatives or tranquillisers (1% and 
0.3%, respectively).
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Relationship between use of particular 
substances and use of other substances  
– All adults (Table 16)
Patterns of polydrug use change when the data for specific drugs 
used was analysed. This table presents the pattern of association 
between the use of one substance and the use of another. For 
example, of those respondents who used alcohol (1392), 33% 
also used tobacco and 4% also used cannabis in the last month.
Overall, it is evident that the use of alcohol and tobacco is 
associated to a lesser extent with the use of other legal or illegal 
drugs than vice-versa. Therefore, of those who had smoked tobacco 
nearly four-fifths (78%) had drunk alcohol. However, for both of 
these substances, the proportions of respondents using them in 
combination with other legal or illegal drugs were quite low.
In contrast, users of cannabis, amphetamine-type stimulants, and 
cocaine were more likely to have used legal substances as well 
as other illegal substances. Of those who had used cannabis 
within the last month, the vast majority (98%) had used alcohol 
and just over three-quarters (76%) had smoked tobacco. Of 
those who had used amphetamine-type stimulants, 93% had 
used alcohol, 61% had used tobacco, 42% cannabis, 4% 
cocaine, 23% had used sedatives or tranquillisers and 18% had 
used anti-depressants.
Use of one substance by users of another 
substance – Gender (Tables 17 & 18)
When comparing alcohol consumption between males and 
females, there is no consistent pattern. Of those who had used 
alcohol, males (5%) were more likely than females (2%) to also 
use cannabis. Conversely, larger proportions of female than male 
users of alcohol reported also using sedatives or tranquillisers 
(7% and 4%, respectively) and anti-depressants (8% and 4%, 
respectively).
Among users of tobacco, larger proportions of males than 
females reported also using alcohol (83% and 73%, 
respectively) and cannabis (9% and 4%, respectively), while 
larger proportions of females than males reported also using 
sedatives or tranquillisers (16% and 9%, respectively) and anti-
depressants (18% and 8%, respectively).
Another significant gender difference among polydrug users was 
for those who used sedatives or tranquillisers, where a larger 
proportion of males (8%) than females (1%) reported also 
using cannabis. Similarly, for users of anti-depressants, males 
(13%) were more likely than females (2%) to also use 
cannabis. It should be noted, that due to small cell counts for 
some of the polydrug combinations the chi-square test was not 
appropriate to determine associations.
Use of one substance by users of another 
substance – Age (Tables 19 & 20)
Differences between young adults aged 15-34 and older adults 
aged 35-64 in the use of many of the substances were 
observed, mainly for alcohol and tobacco users. Among users of 
alcohol, larger proportions of young adults than older adults 
reported using tobacco (39% and 29%, respectively), cannabis 
(5% and 3%, respectively) and amphetamine-type stimulants 
(2% and 0.6%, respectively). However, larger proportions of 
older adults than young adults who used alcohol also reported 
using sedatives or tranquillisers (8% and 2%, respectively) and 
anti-depressants (7% and 4%, respectively).
Similar results were observed among users of tobacco, where 
larger proportions of young adults than older adults reported also 
using alcohol (83% and 73%, respectively), and cocaine (1% 
and 0%, respectively). In contrast, larger proportions of older 
adults than young adults who were users of tobacco reported 
also using sedatives or tranquillisers (20% and 4%, respectively) 
and anti-depressants (17% and 7%, respectively).
Significant differences between young adults and older adults 
were also observed among users of amphetamines-type 
stimulants, where larger proportions of respondents aged 35-64 
than those aged 15-34 reported also using cannabis (100% and 
23%, respectively) and sedatives or tranquillisers (65% and 
10%, respectively). Among users of anti-depressants, young 
adults (13%) were more likely than older adults (3%) to report 
also using cannabis, while older adults (54%) were more likely 
than young adults (34%) to also report the use of sedatives or 
tranquillisers.
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Comparison – Ireland and 
Northern Ireland
A number of important similarities in polydrug use emerged from 
Northern and Ireland.
The first was the proportion (around one-fifth) of respondents in 
both jurisdictions who had not used any drugs (legal or illegal) in 
the last month. It is also important to note that this pattern of 
non-use is not confined to a single gender or age-group. 
However, in both Ireland and Northern Ireland, a larger 
proportion of females than males reported no legal or illegal 
drug use, but there is no significant difference in non-use 
between young and older adults.
Another finding was that the most common form of polydrug 
use among all adults in both jurisdictions is alcohol and tobacco, 
and this combination is more prevalent in Ireland (27%) than in 
Northern Ireland (18%). Larger proportions of males than 
females, and young adults than older adults, reported this 
combination in both Ireland and Northern Ireland.
In both Ireland and Northern Ireland, the largest proportion of 
respondents used alcohol only during the previous month, 50% 
in Ireland compared to 43% in Northern Ireland. The difference 
was most pronounced in the case of older adults; 44% in 
Northern Ireland were current users compared to 53% in Ireland.
The combination of polydrug use for alcohol, tobacco and any 
illegal drugs was reported by a small minority of respondents in 
Ireland (2%) and Northern Ireland (2%). The proportions of 
polydrug use involving any illegal drugs are low in both 
jurisdictions.
Combinations that involved the use of sedatives or tranquillisers 
and anti-depressants were generally higher among older adults 
than young adults in both jurisdictions.
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Table 1: Ireland
Drug use combinations – All adults (15-64)
Last month prevalence Frequency 
n = 4967 
Percent
1 Alcohol only 2487 50.1
2 Alcohol, Tobacco 1315 26.5
3 No legal or illegal drugs 974 19.6
4 Tobacco only 260 5.2
5 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 161 3.3
6 Alcohol, Any illegal drugs¹ 131 2.6
7 Tobacco, Any illegal drugs 120 2.4
8 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 115 2.3
9 Alcohol, Tobacco, Any illegal drugs 108 2.2
10 Alcohol, Sedatives or Tranquillisers 96 1.9
11 Alcohol, Anti-depressants 95 1.9
12 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 79 1.6
13 Tobacco, Anti-depressants 77 1.5
14 Tobacco, Sedatives or Tranquillisers 67 1.4
15 Alcohol, Tobacco, Sedatives or 
Tranquillisers 48 1.0
16 Alcohol, Tobacco, Anti-depressants 48 1.0
17 Sedatives or Tranquillisers, Anti-
depressants 45 0.9
18 Sedatives or Tranquillisers only 32 0.6
19 Anti-depressants only 14 0.3
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 9 0.2
21 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 7 0.1
22 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 5 0.1
23 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 3 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
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Table 2: Ireland
Drug use combinations – Males
 Last month prevalence Frequency 
n =2513 
Percent
1 Alcohol only 1275 50.7
2 Alcohol, Tobacco 739 29.4
3 No legal or illegal drugs 420 16.7
4 Alcohol, Any illegal drugs¹ 101 4.0
5 Tobacco, Any illegal drugs 94 3.7
6 Tobacco only 88 3.5
7 Alcohol, Tobacco, Any illegal drugs 86 3.4
8 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 63 2.5
9 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 46 1.8
10 Alcohol, Sedatives or Tranquillisers 39 1.5
11 Alcohol, Anti-depressants 37 1.5
12 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 35 1.4
13 Tobacco, Sedatives or Tranquillisers 29 1.1
14 Tobacco, Anti-depressants 28 1.1
15 Alcohol, Tobacco, Sedatives or 
Tranquillisers 24 0.9
16 Sedatives or Tranquillisers, Anti-
depressants 22 0.9
17 Alcohol, Tobacco, Anti-depressants 19 0.8
18 Sedatives or Tranquillisers only 17 0.7
19 Anti-depressants only 5 0.2
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 5 0.2
21 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 2 0.1
22 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 2 0.1
23 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 1 0.0
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Table 3: Ireland
Drug use combinations – Females
 Last month prevalence Frequency 
n =2454 
Percent
1 Alcohol only 1213 49.4
2 Alcohol, Tobacco 577 23.5
3 No legal or illegal drugs 554 22.6
4 Tobacco only 173 7.0
5 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 98 4.0
6 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 69 2.8
7 Alcohol, Anti-depressants 59 2.4
8 Alcohol, Sedatives or Tranquillisers 57 2.3
9 Tobacco, Anti-depressants 49 2.0
10 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 45 1.8
11 Tobacco, Sedatives or Tranquillisers 39 1.6
12 Alcohol, Any illegal drugs¹ 31 1.2
13 Alcohol, Tobacco, Anti-depressants 29 1.2
14 Tobacco, Any illegal drugs 26 1.1
15 Alcohol, Tobacco, Sedatives or 
Tranquillisers 24 1.0
16 Sedatives or Tranquillisers, Anti-
depressants 23 1.0
17 Alcohol, Tobacco, Any illegal drugs 22 0.9
18 Sedatives or Tranquillisers only 15 0.6
19 Anti-depressants only 9 0.3
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 4 0.2
21 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 3 0.1
22 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 2 0.1
23 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 2 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
14 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2009
Drug Use in Ireland & Northern Ireland 2006/2007  
Drug Prevalence Survey: Polydrug Use Results Bulletin 5
National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2009
Table 4: Ireland
Drug use combinations – Young adults (15-34)
 Last month prevalence Frequency 
n =2315 
Percent
1 Alcohol only 1081 46.7
2 Alcohol, Tobacco 706 30.5
3 No legal or illegal drugs 466 20.1
4 Tobacco only 116 5.0
5 Alcohol, Any illegal drugs¹ 106 4.6
6 Tobacco, Any illegal drugs 93 4.0
7 Alcohol, Tobacco, Any illegal drugs 87 3.8
8 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 48 2.1
9 Alcohol, Anti-depressants 34 1.5
10 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 33 1.4
11 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 26 1.1
12 Tobacco, Anti-depressants 25 1.1
13 Alcohol, Sedatives or Tranquillisers 21 0.9
14 Tobacco, Sedatives or Tranquillisers 14 0.6
15 Sedatives or Tranquillisers, Anti-
depressants 13 0.6
16 Alcohol, Tobacco, Sedatives or 
Tranquillisers 13 0.5
17 Alcohol, Tobacco, Anti-depressants 10 0.4
18 Sedatives or Tranquillisers only 7 0.3
19 Anti-depressants only 6 0.3
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 4 0.2
21 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 2 0.1
22 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 1 0.1
23 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 1 0.0
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Table 5: Ireland
Drug use combinations – Older adults (35-64)
 Last month prevalence Frequency 
n = 2652 
Percent 
1 Alcohol only 1406 53.0
2 Alcohol, Tobacco 610 23.0
3 No legal or illegal drugs 508 19.2
4 Tobacco only 145 5.5
5 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 114 4.3
6 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 82 3.1
7 Alcohol, Sedatives or Tranquillisers 75 2.8
8 Alcohol, Anti-depressants 61 2.3
9 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 53 2.0
10 Tobacco, Sedatives or Tranquillisers 53 2.0
11 Tobacco, Anti-depressants 52 1.9
12 Alcohol, Tobacco, Sedatives or 
Tranquillisers 35 1.3
13 Sedatives or Tranquillisers, Anti-
depressants 32 1.2
14 Alcohol, Tobacco, Anti-depressants 29 1.1
15 Tobacco, Any illegal drugs¹ 27 1.0
16 Alcohol, Any illegal drugs 26 1.0
17 Sedatives or Tranquillisers only 25 0.9
18 Alcohol, Tobacco, Any illegal drugs 21 0.8
19 Anti-depressants only 7 0.3
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 5 0.2
21 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 4 0.1
22 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 3 0.1
23 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 2 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2009
Bulletin 5
15National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2009
Bulletin 5
Drug Use in Ireland & Northern Ireland 2006/2007  
Drug Prevalence Survey: Polydrug Use Results
Table 6: Ireland













Users of ST2 Users of 
AD3
N (weighted) 4967 3653 1619 128 19 25 147 154
Alcohol 73.4  81.2 90.6 100.0 100.0 65.3 62.1
Tobacco 32.6 36.1  88.3 84.2 80.0 45.6 50.0
Cannabis 2.6 3.2 7.0  78.9 60.0 4.7 5.8
ATS1 0.4 0.5 1.0 11.7  25.0 0.7 0.6
Cocaine 0.5 0.7 1.2 11.7 33.3  0.7 0.0
ST2 3.0 2.6 4.1 5.5 5.3 4.0  38.3
AD3 3.1 2.6 4.8 7.0 5.3 0.0 40.1  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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Table 7: Ireland













Users of ST2 Users of 
AD3
N (weighted) 2513 1966 844 99 13 19 60 58
Alcohol 78.2  87.6 92.0 100.0 100.0 63.9 63.8
Tobacco 33.6 37.6  89.9 92.3 84.2 47.5 48.3
Cannabis 4.0 4.7 10.5  84.6 63.2 6.6 8.6
ATS1 0.5 0.7 1.4 11.1  26.3 0.0 0.0
Cocaine 0.7 1.0 1.9 12.0 38.5  0.0 0.0
ST2 2.4 2.0 3.4 4.0 0.0 0.0  38.6
AD3 2.3 1.9 3.3 5.1 0.0 0.0 36.7  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
Table 8: Ireland













Users of ST2 Users of 
AD3
N (weighted) 2454 1678 776 28 6 6 87 96
Alcohol 68.4  74.4 85.7 100.0 100.0 66.3 61.5
Tobacco 31.6 34.4  85.7 80.0 80.0 44.8 51.0
Cannabis 1.1 1.4 3.1  60.0 50.0 3.4 3.2
ATS1 0.2 0.4 0.5 10.7  33.3 1.1 1.0
Cocaine 0.2 0.4 0.5 10.7 33.3  1.1 0.0
ST2 3.5 3.4 5.0 10.7 16.7 16.7  38.5
AD3 3.9 3.5 6.3 10.7 16.7 0.0 42.5  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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Table 9: Ireland













Users of ST2 Users of 
AD3
N (weighted) 2315 1709 833 97 17 23 30 50
Alcohol 73.8  84.8 93.8 100.0 100.0 70.0 68.0
Tobacco 36.0 41.3  89.7 82.4 78.3 48.3 50.0
Cannabis 4.2 5.3 10.4  76.5 58.3 3.3 7.8
ATS1 0.7 1.0 1.7 13.4  21.7 3.3 2.0
Cocaine 1.0 1.3 2.2 14.4 31.3  3.3 0.0
ST2 1.3 1.2 1.7 1.0 5.9 4.2  24.0
AD3 2.2 2.0 3.0 4.1 5.9 0.0 40.0  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
Table 10: Ireland













Users of ST2 Users of 
AD3
N (weighted) 2652 1935 787 31 2 1 118 103
Alcohol 73.0  77.5 80.6 100.0 100.0 64.1 59.2
Tobacco 29.7 31.5  83.9 100.0 100.0 44.9 50.0
Cannabis 1.2 1.3 3.3  100.0 100.0 5.1 4.9
ATS1 0.1 0.1 0.3 6.5  100.0 0.0 0.0
Cocaine 0.0 0.1 0.1 3.3 50.0  0.0 0.0
ST2 4.4 3.9 6.7 19.4 0.0 0.0  45.6
AD3 3.9 3.2 6.6 16.7 0.0 0.0 39.8  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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Table 11: Northern Ireland
Drug use combinations – All adults (15-64)
 Last month prevalence Frequency 
n = 2002
Percent
1 Alcohol only 851 42.5
2 No legal or illegal drugs 424 21.2
3 Alcohol, Tobacco 363 18.1
4 Tobacco only 84 4.2
5 Alcohol, Tobacco, Any illegal drugs 35 1.7
6 Alcohol, Any illegal drugs 24 1.2
7 Alcohol, Anti-depressants 23 1.1
8 Anti-depressants only 22 1.1
9 Alcohol, Sedatives or Tranquillisers 20 1.0
10 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 19 1.0
11 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 19 1.0
12 Sedatives or Tranquillisers, Anti-
depressants 18 0.9
13 Alcohol, Tobacco, Anti-depressants 17 0.8
14 Alcohol, Tobacco, Sedatives or 
Tranquillisers 16 0.8
15 Sedatives or Tranquillisers only 15 0.8
16 Tobacco, Sedatives or Tranquillisers 14 0.7
17 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 13 0.6
18 Tobacco, Anti-depressants 10 0.5
19 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 4 0.2
20 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 3 0.2
21 Tobacco , Any illegal drugs 3 0.1
22 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 2 0.1
23 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 1 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
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Table 12: Northern Ireland
Drug use combinations – Males
 Last month prevalence Frequency 
n = 993
Percent
1 Alcohol only 452 45.5
2 Alcohol, Tobacco 206 20.7
3 No legal or illegal drugs 184 18.5
4 Tobacco only 37 3.7
5 Alcohol, Tobacco, Any illegal drugs 22 2.3
6 Alcohol, Any illegal drugs 17 1.8
7 Alcohol, Sedatives or Tranquillisers 9 0.9
8 Sedatives or Tranquillisers, Anti-
depressants 8 0.8
9 Tobacco, Sedatives or Tranquillisers 7 0.8
10 Alcohol, Tobacco, Sedatives or 
Tranquillisers 7 0.7
11 Sedatives or Tranquillisers only 6 0.7
12 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 6 0.6
13 Alcohol, Anti-depressants 5 0.5
14 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 5 0.5
15 Alcohol, Tobacco, Anti-depressants 5 0.5
16 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 4 0.4
17 Tobacco, Anti-depressants 4 0.4
18 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 3 0.3
19 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 2 0.2
20 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 2 0.2
21 Tobacco, Any illegal drugs 1 0.1
22 Anti-depressants only 1 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Table 13: Northern Ireland
Drug use combinations – Females
 Last month prevalence Frequency 
n = 1009
Percent
1 Alcohol only 399 39.6
2 No legal or illegal drugs 241 23.8
3 Alcohol, Tobacco 157 15.6
4 Tobacco only 47 4.7
5 Anti-depressants only 21 2.1
6 Alcohol, Anti-depressants 18 1.8
7 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 16 1.5
8 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 14 1.3
9 Alcohol, Tobacco, Any illegal drugs 12 1.2
10 Alcohol, Tobacco, Anti-depressants 12 1.2
11 Alcohol, Sedatives or Tranquillisers 12 1.2
12 Sedatives or Tranquillisers, Anti-
depressants 10 1.0
13 Sedatives or Tranquillisers only 9 0.9
14 Alcohol, Tobacco, Sedatives or 
Tranquillisers 9 0.9
15 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 8 0.8
16 Tobacco, Sedatives or Tranquillisers 6 0.6
17 Tobacco, Anti-depressants 6 0.6
18 Alcohol, Any illegal drugs 6 0.6
19 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 1 0.1
20 Tobacco, Any illegal drugs 1 0.1
21 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 1 0.1
22 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 1 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
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Table 14: Northern Ireland
Drug use combinations – Young adults (15-34)
 Last month prevalence Frequency 
n = 844
Percent
1 Alcohol only 340 40.2
2 Alcohol, Tobacco 192 22.7
3 No legal or illegal drugs 190 22.5
4 Tobacco only 37 4.4
5 Alcohol, Any illegal drugs 21 2.5
6 Alcohol, Tobacco, Any illegal drugs 20 2.4
7 Alcohol, Tobacco, Anti-depressants 8 0.9
8 Anti-depressants only 7 0.8
9 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 4 0.5
10 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 3 0.4
11 Alcohol, Anti-depressants 3 0.3
12 Alcohol, Sedatives or Tranquillisers 3 0.3
13 Tobacco, Any illegal drugs 3 0.3
14 Sedatives or Tranquillisers, Anti-
depressants 2 0.3
15 Alcohol, Tobacco, Sedatives or 
Tranquillisers 2 0.3
16 Tobacco, Sedatives or Tranquillisers 2 0.3
17 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 2 0.2
18 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 2 0.2
19 Tobacco, Anti-depressants 2 0.2
20 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants, Any illegal drugs 1 0.2
21 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 1 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Table 15: Northern Ireland
Drug use combinations – Older adults (35-64)
 Last Month Prevalence Frequency 
n = 1150
Percent
1 Alcohol only 511 44.4
2 No legal or illegal drugs 230 20.0
3 Alcohol, Tobacco 169 14.7
4 Tobacco only 47 4.1
5 Alcohol, Anti-depressants 20 1.7
6 Alcohol, Sedatives or Tranquillisers 18 1.5
7 Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 17 1.5
8 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants 16 1.4
9 Sedatives or Tranquillisers, Anti-
depressants 16 1.4
10 Anti-depressants only 16 1.3
11 Sedatives or Tranquillisers only 15 1.3
12 Alcohol, Tobacco, Any illegal drugs 15 1.3
13 Alcohol, Tobacco, Sedatives or 
Tranquillisers 14 1.2
14 Tobacco, Sedatives or Tranquillisers 12 1.0
15 Alcohol, Sedatives or Tranquillisers, 
Anti-depressants 11 0.9
16 Alcohol, Tobacco, Anti-depressants 9 0.8
17 Tobacco, Anti-depressants 8 0.7
18 Alcohol, Any illegal drugs 3 0.2
19 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Any illegal drugs 2 0.2
20 Alcohol, Tobacco, Sedatives or 
Tranquillisers, Anti-depressants, 
Any illegal drugs 2 0.2
21 Alcohol, Tobacco, Anti-depressants, 
Any illegal drugs 1 0.1
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ For the purpose of this study, “Any illegal drugs” refers to amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
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Table 16: Northern Ireland













Users of ST2 Users of 
AD3
N (weighted) 2002 1392 590 53 20 7 142 150
Alcohol 69.5  78.0 97.8 92.6 100.0 53.0 53.6
Tobacco 29.5 33.1  75.8 61.2 59.7 52.1 48.5
Cannabis 2.6 3.7 6.8  41.6 75.6 3.9 5.1
ATS1 1.0 1.3 2.0 15.5  10.8 3.2 2.4
Cocaine 0.3 0.5 0.7 9.7 3.7  0.0 1.1
ST2 7.1 5.4 12.5 10.5 23.3 0.0  49.2
AD3 7.5 5.8 12.4 14.6 18.5 24.4 52.1  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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Table 17: Northern Ireland













Users of ST2 Users of 
AD3
N (weighted) 993 742 306 36 10 7 57 42
Alcohol 74.7  82.8 96.8 100.0 100.0 55.2 61.6
Tobacco 30.9 34.3  75.0 64.8 59.7 50.8 54.8
Cannabis 3.7 4.8 9.0  48.5 75.6 8.1 12.6
ATS1 1.0 1.3 2.1 13.2  10.8 5.5 3.5
Cocaine 0.7 0.9 1.3 13.9 7.3  0.0 3.9
ST2 5.7 4.2 9.4 12.6 31.4 0.0  58.5
AD3 4.2 3.5 7.6 14.6 14.9 24.4 43.3  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
Table 18: Northern Ireland













Users of ST2 Users of 
AD3
N (weighted) 1009 650 284 16 10 0 85 108
Alcohol 64.5  72.8 100.0 84.9 0.0 51.6 50.5
Tobacco 28.1 31.8  77.5 57.6 0.0 53.0 46.0
Cannabis 1.6 2.5 4.4  34.5 0.0 1.1 2.2
ATS1 1.0 1.3 2.0 20.7  0.0 1.7 2.0
Cocaine 0.0 0.0 0.0 0.0 0.0  0.0 0.0
ST2 8.4 6.8 15.9 5.8 15.1 0.0  45.6
AD3 10.7 8.4 17.6 14.6 22.2 0.0 58.0  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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Table 19: Northern Ireland













Users of ST2 Users of 
AD3
N (weighted) 844 600 276 31 15 5 19 35
Alcohol 71.0  83.5 96.3 90.2 100.0 65.6 62.1
Tobacco 32.8 38.6  68.2 48.7 84.7 54.8 55.5
Cannabis 3.7 5.1 7.8  22.8 65.3 4.9 13.5
ATS1 1.8 2.2 2.6 10.7  15.3 7.6 4.1
Cocaine 0.6 0.8 1.5 9.8 4.9  0.0 4.7
ST2 2.3 2.1 3.8 3.0 9.8 0.0  33.5
AD3 4.2 3.7 7.1 15.1 9.8 34.7 61.8  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
Table 20: Northern Ireland













Users of ST2 Users of 
AD3
N (weighted) 1150 789 312 21 5 2 123 115
Alcohol 68.6  73.0 100.0 100.0 100.0 51.1 51.0
Tobacco 27.1 28.8  87.0 100.0 0.0 51.7 46.3
Cannabis 1.8 2.7 5.9  100.0 100.0 3.7 2.5
ATS1 0.4 0.6 1.5 22.5  0.0 2.5 1.9
Cocaine 0.2 0.3 0.0 9.4 0.0  0.0 0.0
ST2 10.7 8.0 20.4 21.8 65.3 0.0  54.0
AD3 10.0 7.4 17.1 13.8 45.4 0.0 50.6  
All figures are based on weighted data.
All figures are rounded to the nearest decimal place.
All figures are based on valid responses.
¹ Amphetamine-type stimulants (Ecstasy and Amphetamines)
² Sedatives or Tranquillisers
³ Anti-Depressants
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